Skip to content
Nonprofiteer
← INTERNATIONAL LYMPHOMA RADIATION ONCOLOGY FOUNDATION

Form 990-EZ for tax year 2023

Filed by INTERNATIONAL LYMPHOMA RADIATION ONCOLOGY FOUNDATION.

Totals

Total revenue
$84,312
Total expenses
$76,999
Contributions and grants received
$84,185
Grants paid
not reported
Program service revenue
not reported
Membership dues (line 3)
not reported
Investment income (line 4)
$127
Gain or loss on sale of assets (line 5c)
not reported
Gaming and fundraising events, net (line 6d)
not reported
Gross profit on inventory sales (line 7c)
not reported
Other revenue (line 8)
not reported
Total assets, end of year
$154,971
Total liabilities, end of year
not reported
Net assets or fund balances, end of year
$154,971
Program service expenses (Part III)
$74,199

Program services were 96.4% of total expenses calculated — Part III's total program service expenses over total expenses, both as filed.

Mission and programs · 2023

Primary exempt purpose

THE MISSION OF ILROG IS TO IMPROVE THE OUTCOME FOR PATIENTS BY ENCOURAGING THE APPROPRIATE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA. ILROG OBJECTIVES: - TO OPTIMIZE, ADVANCE AND HARMONIZE THE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA PATIENTS. - TO INFORM THE HEMATOLOGY, MEDICAL AND RADIATION ONCOLOGY COMMUNITIES OF THE LYMPHOMA SCENARIOS WHERE APPROPRIATE UTILIZATION OF RADIOTHERAPY IS ADVANTAGEOUS. - TO DEVELOP AND DISSEMINATE EVIDENCE-BASED GUIDELINES FOR RADIOTHERAPY FIELDS, DOSES AND TECHNIQUES FOR ALL TYPES OF LYMPHOMAS. - TO TRAIN RADIATION ONCOLOGISTS WORLDWIDE IN USING MODERN LYMPHOMA RADIOTHERAPY PRINCIPLES AND TECHNIQUES VIA COLLABORATION WITH APPROPRIATE NATIONAL OR REGIONAL SCIENTIFIC SOCIETIES. - TO PROVIDE A WORLDWIDE FORUM FOR RADIATION ONCOLOGISTS WHO TREAT LYMPHOMAS TO DISCUSS AND SHARE INFORMATION AND IDEAS. - TO PROVIDE A SOURCE OF INFORMATION FOR LYMPHOMA PATIENTS EXPLAINING THE ADVANTAGES AND RISKS ASSOCIATED WITH RADIATI

  • 2023 ACCOMPLISHMENTS INCLUDE CONDUCTING AND PUBLISHING RESEARCH IN NEW THERAPIES FOR LYMPHOMA AND MULTIPLE MYELOMA, INCLUDING CAR T CELL. EDUCATIONAL CONFERENCES IN MANCHESTER AND LONDON, UK, AND LYON, FRANCE. CONTINUED EDUCATON OF MEMBERSHIP BY CREATING, PUBLISHING AND CREATING GUIDELINES.

    Expenses $74,199

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part IV

  • Joachim Yahalom MD

    CHAIRMAN

    Total calculated
    $0
    Compensation
    $0
    Benefit plans
    not reported
    Expense account
    not reported
    Hours/week
    12
  • Lena Specht MD

    VICE-CHAIRMA

    Total calculated
    $0
    Compensation
    $0
    Benefit plans
    not reported
    Expense account
    not reported
    Hours/week
    8
  • Tim Illidge MD

    SECRETARY/TR

    Total calculated
    $0
    Compensation
    $0
    Benefit plans
    not reported
    Expense account
    not reported
    Hours/week
    8

Compensation is as filed in Part IV of the Form 990-EZ: compensation, contributions to benefit plans, expense account, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990_ez
Tax year
2023
Filed
30 October 2024
IRS schema version
2023v5.0
Source object
202423199349201342

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.